1. IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation
- Author
-
Changsheng Huang, Anyi Liu, Da Song, Qi Wu, Jingqin Lan, Fuqing Hu, Xuelai Luo, Chentao Shen, Junbo Hu, Li Sun, Yaqi Chen, Lisheng Chen, Yongdong Feng, Sheng-You Huang, Guihua Wang, Feng Xu, Fayong Hu, and Yumeng Yan
- Subjects
STAT3 Transcription Factor ,0301 basic medicine ,medicine.medical_treatment ,Science ,Regulator ,Autophagy-Related Proteins ,General Physics and Astronomy ,Biology ,Article ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,0302 clinical medicine ,Drug Therapy ,Cell Line, Tumor ,Autophagy ,medicine ,Humans ,Protein Interaction Domains and Motifs ,Phosphorylation ,Tumor microenvironment ,Multidisciplinary ,Interleukin-6 ,General Chemistry ,BECN1 ,Janus Kinase 2 ,Gene Expression Regulation, Neoplastic ,Cancer therapeutic resistance ,030104 developmental biology ,Cytokine ,Drug Resistance, Neoplasm ,030220 oncology & carcinogenesis ,Cancer cell ,Cancer research ,Beclin-1 ,Signal transduction ,Colorectal Neoplasms ,Signal Transduction - Abstract
Extracellular cytokines are enriched in the tumor microenvironment and regulate various important properties of cancers, including autophagy. However, the precise molecular mechanisms underlying the link between autophagy and extracellular cytokines remain to be elucidated. In the present study, we demonstrate that IL-6 activates autophagy through the IL-6/JAK2/BECN1 pathway and promotes chemotherapy resistance in colorectal cancer (CRC). Mechanistically, IL-6 triggers the interaction between JAK2 and BECN1, where JAK2 phosphorylates BECN1 at Y333. We demonstrate that BECN1 Y333 phosphorylation is crucial for BECN1 activation and IL-6-induced autophagy by regulating PI3KC3 complex formation. Furthermore, we investigate BECN1 Y333 phosphorylation as a predictive marker for poor CRC prognosis and chemotherapy resistance. Combination treatment with autophagy inhibitors or pharmacological agents targeting the IL-6/JAK2/BECN1 signaling pathway may represent a potential strategy for CRC cancer therapy., IL-6 is an important cytokine in the tumour microenvironment, but its role in regulating autophagy in cancer cells is unclear. Here the authors show that IL-6 activates autophagy in colorectal cancer through the interaction between JAK2 and autophagy regulator, BECN1, which leads to chemotherapeutic resistance.
- Published
- 2021